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OBJECTIVE
To assess whether gestational diabetes mellitus (GDM) can be prevented by a
moderate lifestyle intervention in pregnant women who are at high risk for the
disease.
RESEARCH DESIGN AND METHODS
Two hundred ninety-three women with a history of GDM and/or a prepregnancy
BMI of ‡30 kg/m2 were enrolled in the study at <20 weeks of gestation and were
randomly allocated to the intervention group (n = 155) or the control group
(n = 138). Each subject in the intervention group received individualized counseling
on diet, physical activity, and weight control from trained study nurses, and had one
group meeting with dietitian. The control group received standard antenatal care.
Thediagnosis ofGDMwas based upon a 75-g, 2-h oral glucose tolerance test at 24–28
weeks of gestation.
RESULTS
A total of 269 women were included in the analyses. The incidence of GDM was
13.9% in the intervention group and 21.6% in the control group ([95% CI 0.40–
0.98%] P = 0.044, after adjustment for age, prepregnancy BMI, previous GDM
status, and the number of weeks of gestation). Gestational weight gain was lower
in the intervention group (20.58 kg [95% CI 21.12 to 20.04 kg] adjusted P =
0.037). Women in the intervention group increased their leisure time physical
activity more and improved their dietary quality, compared with the women in
the control group.
CONCLUSIONS
Amoderate individualized lifestyle intervention reduced the incidence of GDM by
39% in high-risk pregnant women. These ﬁndings may have major health conse-
quences for both the mother and the child.
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The prevalence of overweight and obe-
sity are increasing worldwide (1). Obe-
sity constitutes a major risk factor for
type 2 diabetes (2), which it is estimated
will affect almost half a billion people by
2030 (3,4). The global health care ex-
penditure on diabetes is expected to to-
tal at least 490 billion U.S. dollars (5). In
theU.S. andother developed countries, up
to 60% of women of reproductive age are
overweight or obese (1,6). Obesity is
strongly associatedwith gestational diabe-
tesmellitus (GDM),which affects 2–18%of
all pregnancies globally (7–9). Regardless
of the criteria used, the incidence of GDM
is increasing (7–9). GDM is a heteroge-
neous disorder, resulting from an interac-
tion between genetic and environmental
risk factors (3). It is characterized by insulin
resistance as well as impaired pancreatic
b-cell function and is a well-known predic-
tor of future diabetes (2). Type 2 diabetes
is diagnosed in up to 10%ofwomenwith a
historyofGDMsoonafter delivery.During a
10-year follow-up, the risk can be as high as
70% (10).
GDM and obesity are both indepen-
dently associated with adverse maternal
and neonatal outcomes (11–13). Mater-
nal overweight and GDM may also in-
crease the offspring’s predisposition to
obesity, impaired glucose regulation,
and GDM, creating a vicious cycle leading
to an accumulating risk in the next gener-
ation (14–17). Thus, there is an urgent
need for safe and effective interventions
aimed at preventing GDM.
Findings in lifestyle intervention stud-
ies focusing upon the prevention of type
2 diabetes have been encouraging,
showing a risk reduction of 58% (18,19).
No similar ﬁndings among high-risk
women for GDM have been published.
Adherence to a healthy lifestyle before
pregnancy is, however, associated with
reduced GDM risk (20). Several lifestyle
intervention trials targeted at limiting
gestational weight gain or preventing
obesity-related perinatal complications,
including GDM, have been performed
(21–29). However, the results have been
inconsistent; some studies (22,25,27,28)
have been successful in reducing gesta-
tional weight gain, but the effect on
GDM incidence has been minor (23–29).
The primary outcome of the Finnish
Gestational Diabetes Prevention Study
(RADIEL) was to examine the effect of
combined moderate physical activity
and diet intervention in high-risk
women on the incidence of GDM in a
randomized controlled study setting.
STUDY DESIGN AND METHODS
The RADIEL
The RADIEL is a multicenter randomized
controlled intervention study targeting
women at high risk for GDM. The study
was conducted between February 2008
and January 2014 in all three maternity
hospitals of the Helsinki metropolitan
area (Helsinki University Central Hospital,
Department of Obstetrics and Gynecol-
ogy; Ka¨tilo¨opistoMaternity Hospital; Jorvi
Hospital) and in the South-Karelia Central
Hospital in Lappeenranta, in Finland.
Eligible participants for the study were
women aged$18 years, pregnant at,20
weeks of gestation, with a history of GDM
and/or a prepregnancy BMI of$30 kg/m2.
Exclusion criteria were type 1 or type 2
diabetes, or GDM diagnosed before 20
weeks of gestation; use of medication
that inﬂuences glucose metabolism, such
as continuous therapywith oral corticoste-
roids or metformin; multiple pregnancy;
physical disability; current substance
abuse; severe psychiatric disorder; and sig-
niﬁcant difﬁculty in cooperating (e.g., in-
adequate Finnish language skills).
Participants were recruited fromobese
women primarily in association with the
ﬁrst trimester screening ultrasound and
women with prior GDM by personal in-
vitation letters sent out based on data in
the hospital registry. In addition, notices
in newspapers, social media, and antena-
tal clinicswere used. In the randomization
process, we used randomly permuted
blocks; stratiﬁed by risk factors (BMI
$30 kg/m2, history of GDM). The ran-
domization was performed by a study
nurse and by dispensing the next sequen-
tially numbered subject code andopening
the corresponding code envelope, which
included the intervention arm to be as-
signed to the subject.
Participants entered the study volun-
tarily, signed an informed consent form,
and were allowed to discontinue the
study at any time point. The study was
performed in compliance with the Decla-
ration of Helsinki, approved by the Ethics
Committees of Helsinki University Central
Hospital (14 September 2006, Dnro 300/
E9/06) and South-Karelia Central Hospital
(11 September 2008, Dnro M06/08), and
registered at clinicaltrials.gov (clinical trial
reg. no. NCT01698385). Because of tech-
nical problems on the clinicaltrials.gov
website, the initial date of the RADIEL
was incorrectly changed to 11 September
2012when the clinicaltrials.gov account for
the RADIEL follow-up study was created.
The original clinicaltrials.gov registration
was performed in 2008, prior to the ﬁrst
patient being enrolled in the study.
A sample of ;280 pregnant women
(140 in each group) was required to de-
tect differences in the incidence of GDM
between the intervention (20%) and
control (35%) groups of 15% (a = 0.05,
power = 80%). We assumed a 40% drop-
out rate.
Study Design
The intervention design and study
methods have been published in detail
elsewhere (30). This study focuses only
upon high-risk pregnant women at,20
weeks of gestation.
The participants in the intervention
group received lifestyle counseling from
study nurses and dietitians who were spe-
ciﬁcally trained for their tasks. The partic-
ipants visited the study nurse three times
during pregnancy. These visits were struc-
tured, but the counseling was individual-
ized according to the stage of the
pregnancy. At the time of study enroll-
ment, the participants attended one 2-h
group counseling session led by a dietitian.
The study visits took place at the following
time: the baseline visit at 13.3 weeks of
gestation (interquartile range [IQR] 12.0–
14.6 weeks of gestation); the second visit
at 23.1 weeks of gestation (IQR 22.4–24.1
weeks of gestation); and the third visit at
35.1 weeks of gestation (IQR 34.4–35.6
weeks of gestation). In addition, the par-
ticipants visited antenatal clinics according
to standard national practice.
For women with a prepregnancy BMI of
$30 kg/m2, the recommendation was no
weight gain during the ﬁrst two trimesters.
The dietary advice was based on contem-
porary Nordic Nutrition Recommendations
(2004) (31). The dietary counseling focused
on optimizing participants’ consumption of
vegetables, fruits and berries, whole-grain
products rich in ﬁber, low-fat dairy prod-
ucts, vegetable fats high in unsaturated
fatty acids, ﬁsh, and low-fatmeat products,
and a lower intake of sugar-rich foods.
Regarding physical activity, the aim
was to achieve a minimum of 150 min
of moderate-intensity physical activity
(32,33) per week and to adopt an overall
active lifestyle. The participants and the
study nurses planned, and during the
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follow-up updated, an individual physical
activity program. Participants had access,
free of charge, to public swimming pools
and/or guidedexercise groups onceaweek
provided by the municipalities.
In the control group, participants re-
ceived general information leaﬂets on
diet and physical activity usually provided
by local antenatal clinics. Also, during
pregnancy the control group participants
visited the study nurse three times, to
make measurements, obtain blood sam-
ples, and administer questionnaires, as
well as antenatal clinics according to stan-
dard practice.
Outcomes and Data Collection
The primary end point in the RADIEL was
the incidence of GDM, which was deﬁned
as one ormore pathological glucose values
in a 75-g, 2-h oral glucose tolerance test
(OGTT; run by a central laboratory) with
the followingdiagnostic thresholds: fasting
plasma glucose $5.3 mmol/L, 1-h value
$10.0 mmol/L, and 2-h value $8.6
mmol/L (34). All participants underwent
an OGTT at the time of study enrollment
and again at ;24–28 weeks of gestation
(second trimester) unless insulin or met-
formin treatment was initiated earlier.
Blinded-study physicians reviewed partici-
pants’ obstetric records and conﬁrmed
maternal and neonatal diagnoses. Fasting
plasma glucose concentrations andweight
change, incidence of preeclampsia and
gestational hypertension, andmode of de-
livery were secondary outcomes. Pre-
eclampsia was deﬁned as a systolic blood
pressure of$140mmHgor diastolic blood
pressure of$90 mmHg occurring after 20
weeks of gestation in a previously normo-
tensive woman combined with new-onset
proteinuria of $0.3 g/24 h (35). Gesta-
tional hypertension was deﬁned similarly
but without the presence of proteinuria
andessential hypertensionas similar blood
pressure levels occurring before 20 weeks
of gestation.
At each visit, participants in both groups
ﬁlled in questionnaires and underwent
physical examinations that included an-
thropometric and blood pressure mea-
surements and blood sampling. Antenatal
clinic records served as a data source for
prepregnancy weight.
A food frequency questionnaire de-
signed for this study was ﬁlled in before
each visit to the study nurse. To mea-
sure the general adherence to the rec-
ommended diet, a dietary index was
developed based on the food frequency
questionnaire, with higher scores indicat-
ing better diet quality. The dietary index
includes 11 components that represent
each topic of the counseling and were
scored based on reported intake fre-
quency, as follows: snacks (0–2 points),
sugar-sweetened beverages (0–1 point),
vegetables (0–2 points), fruits and berries
(0–1 point), low-fat cheese (0–1 point),
cooking fat (0–1 point), spread fat (0–2
points), fast food (0–1 point), high-ﬁber
bread and cereals (0–2 points), ﬁsh (0–2
points), and low-fat milk (0–2 points). The
highest score (17 points) was set to reﬂect
the highest adherence to the recom-
mended intake of each score item.
Evaluation of leisure-time physical ac-
tivity was based on the self-reported time
spent weekly on physical activity that
makes a participant at least slightly out
of breath and sweaty. Prepregnancy
physical activity was assessed at baseline
in a similar way.
Statistics
The data are presented as means with SDs,
as medians with IQRs, or as counts with
percentages. The comparison between
groups was made by using a t test, x2
test, or Mann-Whitney test. When using
adjustedmodels, ANCOVA, a logistic regres-
sion model, or a median regression (least-
absolute-value) model was applied.
Repeated measures were analyzed using a
generalized estimating equation (GEE)
model with the unstructured correlation
structure. GEEs were developed as an ex-
tension of the general linear model to ana-
lyze longitudinal and other correlated data.
GEE models take into account the correla-
tion between repeated measurements in
the same subject; models do not require
complete data and can be ﬁtted even
when individuals do not have observations
at all time points. In the case of violation of
the assumptions (e.g., nonnormality), a
bootstrap-type test was used (10,000 repli-
cations). The normality of the variables was
tested by using the Shapiro-WilkW test. All
statistical analyses are performed unad-
justed and adjusted for age, prepregnancy
BMI, previous GDM status, weeks of gesta-
tion, and baseline values. All analyses were
performed using STATA software (version
13.1; StataCorp LP, College Station, TX).
RESULTS
In total, 540 women who were at high risk
for GDM were recruited to the study. Of
these, 247 women did not meet the study
inclusion criteria. The most common rea-
son (28.7%) for not being included was a
pathological OGTT result. The number of
pregnant women included in the analysis
was 269; 144 were allocated to the inter-
vention group, and 125 were allocated to
the control group (Fig. 1).
Demographic and clinical characteris-
tics did not differ between the interven-
tion group and the control group at
baseline (Table 1). Of the participants,
25% (n = 66) reported a chronic disease,
most commonly asthma, with no differ-
ences between the groups. Parental his-
tory of diabetes was present in 22% of the
participants, with no group differences.
Both study groups visited antenatal clinics
four times before the second-trimester
OGTT (intervention groupmean 4.2 times,
SD 1.20 times; control group mean 4.2
times, SD 1.69 times).
GDM
GDM was diagnosed in 20 participants
(13.9% [95% CI 8.7–20.6%]) in the inter-
vention group and in 27 participants
(21.6% [95%CI 14.7–29.8%]) in the control
group (P = 0.097, unadjusted; P = 0.044,
after adjustment for age, prepregnancy
BMI, previous GDM status, and number
of weeks of gestation at the time of the
diagnostic OGTT). The crude relative risk
for GDM was 0.64 (95% CI 0.38–1.09) in
the intervention group.Women belonging
to the intervention group had a crude re-
duction in fasting plasma glucose concen-
tration of20.18mmol/L (95% CI20.24 to
20.12 mmol/L) from baseline to the third
trimester compared with 20.07 mmol/L
(95% CI 20.13 to 20.02 mmol/L) in the
control group (P = 0.026, unadjusted; P =
0.011, after adjustment for age, prepreg-
nancyBMI, previousGDMstatus, thenum-
ber of weeks of gestation, and baseline
glucose concentration). In the intervention
group, the 2-h glucose value increased
from baseline to second trimester by
0.54 mmol/L (95% CI 0.35–0.72 mmol/L),
and in the control group by 0.55 mmol/L
([95% CI 0.33–0.78 mmol/L] P = 0.92, un-
adjusted; P = 0.42, after adjustment for
age, prepregnancyBMI, previousGDMsta-
tus, the number ofweeks of gestation, and
baseline glucose concentration).
Weight Change
There was a difference in gestational
weight gain between the intervention
group (2.5 kg [95% CI 2.1–3.0]) and the
control group (3.1 kg [95% CI 2.7–3.5])
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from baseline to the second trimester (at
the time of the OGTT at week 23.4 on av-
erage), and the mean difference was
20.5 kg ([95% CI21.1 to 0.05] P = 0.072,
unadjusted; P = 0.039, after adjustment for
age, previous GDM status, the number of
weeks of gestation, and baseline weight).
The gestational weight gain was 7.6 kg
(95% CI 6.7–8.3 kg) in the intervention
group and 7.7 kg (95% CI 7.1–8.4 kg) in
the control group from baseline to the
third trimester, and the mean difference
was20.2 kg ([95%CI21.1 to 0.8] P = 0.74,
unadjusted; P = 0.37, after adjustment for
age, previous GDM status, the number of
weeks of gestation, and baseline weight).
Dietary Quality and Physical Activity
The dietary index score improved more
among women in the intervention
group (0.7 [95% CI 0.3–1.1]) compared
with those in the control group (0.3
[95% CI 20.1 to 0.7]), and the mean
difference was 0.4 ([95% CI 20.1 to
1.0] P = 0.16, unadjusted; P = 0.037, af-
ter adjustment for age, prepregnancy
BMI, previous GDM status, the number
of weeks of gestation, and baseline
values).
Women in the intervention group in-
creased their median weekly leisure
time physical activity by 15 min (95%
CI 1–29 min), while the physical activi-
ties of women in the control group
remained unchanged (P = 0.17,
unadjusted; P = 0.029, after adjustment
for, age, prepregnancy BMI, previous
GDM status, the number of weeks of
gestation, and baseline values). Of the
women in the intervention group and
the control group, 26% and 23%, respec-
tively, met the physical activity goal of
150 min/week in the second trimester,
with no signiﬁcant differences between
the groups.
Other Maternal Pregnancy and Birth
Outcomes
There were no differences in the other
maternal pregnancy or birth outcomes
assessed between the intervention and
the control group (Table 2).
CONCLUSIONS
This is, to our knowledge, the ﬁrst random-
ized controlled lifestyle intervention trial
that has succeeded in reducing the overall
incidence of GDM among high-risk preg-
nant women. As a result of the combined
moderate physical activity and diet inter-
vention, the overall incidence of GDMwas
reduced by 39%. The participants in the
intervention group increased their physical
activity and improved their dietary quality
during pregnancy, indicating a real effort
to change their overall lifestyle in a health-
ier direction.By contrast, the control group
participants did not increase their physical
activity or improve the dietary quality in a
signiﬁcant manner. Average weight gain
during pregnancy was modest in both
groups. Other maternal and neonatal out-
comes, including birth size, were similar in
both groups.
The results of this lifestyle intervention
study in pregnant women who are at high
risk of GDM are encouraging and are sim-
ilar to ﬁndings frommajor type 2 diabetes
prevention studies (18,19). It is worth
keeping in mind that since the women
participating in the RADIEL were women
who were at high risk for GDM, the
women in the control group also received
general health advice, for example, in
weight control at antenatal clinics. There-
fore, the control group is more of a mini-
intervention group than a pure control
group. We believe that in an unselected
high-risk population the impact of this
kind of lifestyle intervention could be
even more pronounced.
Previous type 2 diabetes prevention
studies, including the FinnishDiabetes Pre-
vention Study (18) and the Diabetes Pre-
ventionProgram (19), have shown that the
prevention of type 2 diabetes is possible
and feasible by lifestyle intervention. How-
ever, these studies have been criticized for
being too labor intensive and therefore
not directly applicable to a primary health
care setting (36). The RADIEL protocol and
design were much less resource and labor
Figure 1—Flowchart of the RADIEL study.
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intensive, including only three visits to the
study nurse and one group visit to the
dietitian during pregnancy.
Why was the RADIEL successful? One
possible explanation is the high-risk status
of the women recruited to the study. In
several previous GDM and other lifestyle
intervention studies during pregnancy
(21–24,26,28,29), the women recruited
were only at a modest risk for the devel-
opment of GDM. This kind of study setting
would need a bigger sample size to reveal
the effect of a lifestyle intervention. In the
RADIEL, the intervention was targeted at
high-risk pregnant women with a history
of GDM and/or a BMI of$30 kg/m2. One
indication of the participants’ high GDM
risk was the high prevalence of pathologi-
cal OGTT results already existing at the
beginning of the pregnancy. It is known
that the largest effect of a lifestyle inter-
vention is observed in high-risk individuals
(18,19).
Our nutrition and physical activity
counseling was also individualized and
comprehensive. At baseline, the study
nurses identiﬁed possible lifestyle factors
that needed attention, and the counsel-
ing was tailored and focused. We also
considered personal preferences of the
participant in counseling (e.g., when
choosing the type of physical activity).
This probably helped the participants to
engage in activities according to personal
preferences. The intervention started
early in gestation, allowing for a longer
intervention period. This may have inﬂu-
enced physical activity levels positively.
Taking into account that pregnancy is an
exceptional time to make lifestyle
changes, the counseling was modiﬁed
during pregnancy; that is, if antenatal
contractions occurred, and the partici-
pant was unable to exercise, the counsel-
ing focused more on dietary aspects.
Table 1—Baseline demographic and clinical characteristics of the participants in the intervention and control groups
Intervention group
(n = 144)
Control
group
(n = 125) P value
Age (years) 32.3 (4.9) 32.6 (4.5) 0.60
Body weight (kg)
Prepregnancy 87.4 (18.1) 88.3 (16.4) 0.67
At baseline 89.2 (17.9) 89.3 (15.9) 0.98
Height (m) 1.66 (0.07) 1.66 (0.06) 0.81
BMI (kg/m2)
Prepregnancy 31.5 (6.0) 32.0 (5.5) 0.54
At baseline 32.2 (5.9) 32.3 (5.4) 0.84
Gestational age at baseline (weeks) 13.2 (12.3–14.8) 13.3 (11.9–14.4)
Educational status at baseline, n (%) 0.60
Basic education only 4 (3) 3 (2)
Vocational education 38 (26) 26 (21)
Upper secondary school 13 (9) 8 (7)
Upper secondary school and vocational education 46 (32) 50 (41)
Higher education 43 (30) 35 (29)
Previous deliveries, n (%) 0.99
None 61 (42) 52 (42)
1 42 (29) 38 (30)
2 29 (20) 24 (19)
3+ 12 (8) 11 (9)
Prior GDM, n (%) 50 (35) 38 (30) 0.45
Blood pressure
Systolic (mmHg) 123 (13) 121 (14) 0.21
Diastolic (mmHg) 78 (9) 77 (9) 0.28
Total cholesterol (mmol/L) 4.94 (0.91) 4.92 (0.86) 0.88
HDL cholesterol (mmol/L) 1.73 (0.33) 1.75 (0.30) 0.61
Total triglycerides (mmol/L) 1.31 (0.52) 1.38 (0.75) 0.37
Fasting glucose (mmol/L) 4.87 (0.24) 4.89 (0.24) 0.45
2-h glucose (mmol/L) 5.78 (1.05) 5.98 (1.09) 0.13
HbA1c
% 5.2 (0.3) 5.2 (0.3) 0.47
mmol/mL 33.5 (3.0) 33.2 (3.0) 0.53
Insulin (mU/L) 8.48 (4.56) 8.44 (4.56) 0.98
HOMA-IR 1.74 (0.94) 1.79 (0.90) 0.67
Smoking, n (%) 6 (4) 4 (3) 0.68
No alcohol use, n (%) 139 (97) 114 (94) 0.37
Dietary index at baseline 10.1 (2.9) 9.7 (2.5) 0.30
Physical activity at baseline (min/week) 60 (30–130) 60 (30–150) 0.92
Data are the mean (SD) or median (IQR), unless otherwise indicated. HbA1c, hemoglobin A1c; HOMA-IR, HOMA for insulin resistance.
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The study nurses in RADIEL were mid-
wives with strong expertise in counsel-
ing pregnant women; this probably
increased the participants’ conﬁdence
in the study protocol. The lifestyle ad-
vice provided was designed to be easily
implemented and applicable to every-
day life.
The dietary score applied in the study
showed a signiﬁcant but small improve-
ment in the adherence to dietary rec-
ommendations in the intervention
group. This kind of holistic approach
has proven fruitful in the prevention
and management of type 2 diabetes
(37). Even a small change in dietary
choices can be important when applied
at a population level (38). The interven-
tion group also increased their leisure
time physical activity level and gained
less weight than the women in the con-
trol group from baseline to the second
trimester when the GDM diagnosis was
set. Despite the fact that only a small
proportion of the women in the inter-
vention group reached the physical ac-
tivity goals, and the difference in weight
gain was modest between the groups, it
is obvious that the individual changes in
lifestyle do not need to be large but
together they have a beneﬁcial effect
on the reduction of the incidence of
GDM.
Since the RADIEL was performed in a
white Caucasian population, the validity
of generalizing the results needs to be
discussed. However, we suggest that it is
possible to generalize the results, at
least to some extent, since the study
protocol was simple and modiﬁable,
and thus easy to implement in the dif-
ferent societies and ethnic groups.
Focusing upon a selected group of
women with a high risk for the develop-
ment of GDM may be considered a po-
tential weakness, since, for example,
overweight women at the population
level may form a greater proportion of
women in whom GDMwill develop than
the obese population alone. On the
other hand, if overweight women or
women with previous macrosomia
would have been recruited to the trial,
the heterogeneity of the study group
would have been increased markedly.
This could also have had effects on the
intervention results (24,26,28,29). We
believe that in the RADIEL we have
been able to identify a real high-risk
group that is also the most likely to ben-
eﬁt from a lifestyle intervention during
pregnancy. Our study ﬁndings show that
modest changes in several lifestyle-
associated factors have a large overall
effect on GDM risk. However, a larger
sample size would probably have been
needed to see an effect on other mater-
nal or neonatal outcomes.
We have shown that GDM can be pre-
vented in a high-risk population by simple,
easily applicable lifestyle interventions.
Our ﬁndings suggest that individualized
lifestyle intervention should be initiated
in early pregnancy in high-risk women
and continued throughout pregnancy.
These results are unique and highly prom-
ising. Preventing GDM may have major
short- and long-term health consequences
for both the mother and the child.
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